To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect.

First page of article

With consumer devices becoming increasingly affordable, virtual reality (VR) bears therapeutic promise for psychiatry and psychotherapy. Nevertheless, there remains a research-to-practice gap as advances in VR technology outpace clinical research: VR therapeutics practical for day-to-day clinical care remain largely unavailable, inaccessible, or unaffordable. This article returns to three foundational promises of VR: enhancing treatments already feasible in the clinic, making feasible treatments impractical in the clinic, and making possible “impossible” treatments in the clinic. These are discussed in terms of current state of research; whether VR therapeutics are available, accessible, and affordable to frontline clinicians; limitations; and areas of growth via practical examples. This is followed by a discussion on clinical research approach to further bridge the research-to-practice gap: first, using in research only VR devices that are practical for frontline clinics, and second, developing VR-therapeutics with scalability and excellence in mind—through optimization and a team-science approach.

To access this article, please choose from the options below

Purchase access to this article

Claim Access

If you are a current subscriber with Society Membership or an Account Number, claim your access now.

Subscribe to this title

Purchase a subscription to gain access to this and all other articles in this journal.

Institutional Access

Visit ScienceDirect to see if you have access via your institution.


Linked Articles

Unknown widget #d2170c4d-a9cf-482f-ac17-ef77d57a1866

of type linkedContentList

Related Articles

Unknown widget #c2ffda61-8426-42f7-926b-03d7330eede2

of type relatedArticleListWidget